StockData
Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc. (MIST) stock

MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.41+0.05 (+13.21%)

Close on Nov 17, 2026Market cap $51.44MP/E –Yield –

Milestone Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Milestone Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$61.29M. For fiscal 2025 it was -$49.04M. The highest annual figure on record is -$21.05M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$49.04M–
FY2024Dec 31, 2024-$28.85M–
FY2023Dec 31, 2023-$46.42M–
FY2022Dec 31, 2022-$52.47M–
FY2021Dec 31, 2021-$33.22M–
FY2020Dec 31, 2020-$50.73M–
FY2019Dec 31, 2019-$51.15M–
FY2018Dec 31, 2018-$21.05M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$22.71M–
Q1 FY2026Mar 31, 2026-$16.05M–
Q4 FY2025Dec 31, 2025-$12.78M–
Q3 FY2025Sep 30, 2025-$9.75M–
Q2 FY2025Jun 30, 2025-$12.57M–
Q1 FY2025Mar 31, 2025-$13.95M–
Q4 FY2024Dec 31, 2024-$6.84M–
Q3 FY2024Sep 30, 2024-$7.02M–
Q2 FY2024Jun 30, 2024-$6.05M–
Q1 FY2024Mar 31, 2024-$8.93M–
Q4 FY2023Dec 31, 2023-$9.80M–
Q3 FY2023Sep 30, 2023-$12.16M–
Q2 FY2023Jun 30, 2023-$10.56M–
Q1 FY2023Mar 31, 2023-$13.90M–
Q4 FY2022Dec 31, 2022-$12.86M–
Q3 FY2022Sep 30, 2022-$11.57M–
Q2 FY2022Jun 30, 2022-$14.09M-1487.7%
Q1 FY2022Mar 31, 2022-$13.95M–
Q4 FY2021Dec 31, 2021-$12.38M–
Q3 FY2021Sep 30, 2021-$9.39M–
Q2 FY2021Jun 30, 2021$1.02M–
Q1 FY2021Mar 31, 2021-$12.47M–
Q4 FY2020Dec 31, 2020-$8.76M–
Q3 FY2020Sep 30, 2020-$7.33M–
Q2 FY2020Jun 30, 2020-$16.56M–
Q1 FY2020Mar 31, 2020-$18.08M–
Q4 FY2019Dec 31, 2019-$16.60M–
Q3 FY2019Sep 30, 2019-$8.30M–
Q2 FY2019Jun 30, 2019-$11.52M–
Q1 FY2019Mar 31, 2019-$14.73M–
Q4 FY2018Dec 31, 2018-$7.31M–
Q3 FY2018Sep 30, 2018-$5.59M–
Q2 FY2018Jun 30, 2018-$3.42M–
Q1 FY2018Mar 31, 2018-$4.72M–

More Milestone Pharmaceuticals figures

See a number that looks wrong?